Agenus Consensus Price Target Increased by 35.04% to $26.86

Agenus' average one-year analyst price target was revised to $26.86 per share, up 35.04% from the prior $19.89 mean as of September 11, 2026. The increase signals a more constructive analyst outlook for the biotech company, though the figures are aggregated targets rather than a company-specific operational update.